Pathstone Holdings’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,607	Closed	-$227K	–	2315
2024 Q4	$227K	Buy	+7,607	New	+$227K	﹤0.01%	2109
2024 Q2	–	Sell	-10,559	Closed	-$165K	–	2338
2024 Q1	$165K	Buy	+10,559	New	+$165K	﹤0.01%	2167